| This article is ratedStart-class on Wikipedia'scontent assessment scale. It is of interest to the followingWikiProjects: | |||||||||||
| |||||||||||
Ideal sources for Wikipedia's health content are defined in the guidelineWikipedia:Identifying reliable sources (medicine) and are typicallyreview articles. Here are links topossibly useful sources of information aboutMesoridazine.
|
"Mesoridazine partially derives its name from the prefix "Meso"[citation needed] which means "middle" which is the center of the brain called the limbic system where most dopaminergic activity takes place."
I consider this assertion as highly doubtful; it may be somehow plausible, but I think, that "Mesoridazine" comes more likely from the chemical structure, where "Meso-" stands forMethylsulfonyl-, and -ridazine as a common base for piperidine-side-chain-phenotiazine neuroleptics.However, I didn't found a source for this speculation, so I will not change this statement in tis way; is it relevant enough to be incorporated into the article at the moment (at least, as long as unsourced)?--84.163.78.12616:41, 16 August 2007 (UTC)[reply]
Changed to derived from MEthylSulfOxy- group, analog to Thioridazine.These articles are an attraction point to editors who wonder how everything is apparently connected to everything in the Universe.70.137.164.136 (talk)23:58, 1 August 2008 (UTC)[reply]
The lead says the drug was withdrawn in the US in 2004 due to safety concerns. The source for this ismedlineplus.gov which does say it was withdrawn, and does say potentially life-threatening issues, but doesnot say it was withdrawnbecause of that. Moreover, the2021 report] by the US FDA addedhere claims it wasnot withdrawn for safety issues. My guess is that it was voluntarily withdrawn in 2004, and not forced to be withdrawn. Does anyone know precisely what happened here? When/why it was withdrawn?Kimen8 (talk)14:42, 3 September 2024 (UTC)[reply]